BIOA qualifies for the Watch on decline depth. It is down -22.0% from its rolling 252-day high of $24.00, set on 2026-01-15 — 119d ago. It additionally carries a Recovering badge — see below.

Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — BIOA is still Watch because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. BIOA is down -22.0% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

At $18.71, BIOA sits 75.0% of the way from its 52-week low ($2.88) to its 52-week high ($24.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

The current 22.0% decline accrued over 119d, which annualizes to roughly -67.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 43 Amber, 46 Watch, with 54 showing recovering structural signals. Median sector decline is -35.8% — BIOA's decline is shallower than the sector median.